Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Barry Moze. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Barry Moze har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:HZNP / Horizon Therapeutics Plc EVP, Chief Admin. Officer 4.834
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Barry Moze. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Barry Moze som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9.678 4.834 -66,69
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9.222 9.223 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9.314 18.628 -33,33
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12.095 12.095 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -24.650 0 -100,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -49.841 138.174 -26,51 101,84 -5.075.807 14.071.640
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 47.375 188.015 33,69
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 64.959 140.640 85,83
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -72.300 0 -100,00
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -443 0 -100,00
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -3.000 162.181 -1,82
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5.724 75.681 -7,03 115,45 -660.836 8.737.371
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.763 81.405 -7,67 114,43 -773.890 9.315.174
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -17.867 88.168 -16,85 113,56 -2.028.977 10.012.358
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.151 106.035 -5,48 112,60 -692.603 11.939.541
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -15.856 112.186 -12,38 111,75 -1.771.908 12.536.786
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -23.382 128.042 -15,44 110,17 -2.575.995 14.106.387
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 72.300 151.424 91,38 14,48 1.046.904 2.192.620
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 443 79.124 0,56 11,81 5.232 934.454
2021-11-05 2021-11-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 3.000 78.681 3,96 22,14 66.420 1.741.997
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 14.514 14.514
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3.215 75.681 -4,07 102,50 -329.538 7.757.302
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 7.257 78.896 10,13
2021-07-09 2021-07-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -14.626 71.639 -16,95 93,12 -1.361.973 6.671.024
2021-07-09 2021-07-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -12.350 86.265 -12,52 92,64 -1.144.104 7.991.590
2021-07-09 2021-07-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -8.100 98.615 -7,59 91,35 -739.935 9.008.480
2021-04-13 2021-04-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.165 105.665 -5,51 90,30 -556.671 9.541.053
2021-04-13 2021-04-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -8.195 111.830 -6,83 89,60 -734.242 10.019.565
2021-04-13 2021-04-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -51.253 120.025 -29,92 88,70 -4.546.136 10.646.205
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 14.512 14.512
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 3.931 3.931
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -871 171.278 -0,51 87,17 -75.925 14.930.303
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 1.965 172.149 1,15
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
M - Exercise -5.819 5.821 -49,99
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.578 170.184 -1,49 77,43 -199.615 13.177.347
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.819 172.762 3,49
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12.094 24.190 -33,33
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17.260 0 -100,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -24.649 24.650 -50,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -52.858 166.943 -24,05 36,10 -1.908.174 6.026.642
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 65.089 219.801 42,07
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 54.003 154.712 53,62
2021-01-06 2021-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 27.942 27.942
2020-11-06 2020-11-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.553 100.709 -6,11 81,58 -534.572 8.215.508
2020-11-06 2020-11-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.994 107.262 -1,83 80,49 -160.495 8.633.390
2020-11-06 2020-11-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -27.764 109.256 -20,26 79,03 -2.194.095 8.634.130
2020-11-06 2020-11-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -41.189 137.020 -23,11 78,37 -3.228.097 10.738.641
2020-07-07 2020-07-07 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2020-07-07 2020-07-07 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -17.257 443 -97,50
2020-07-07 2020-07-07 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -7.819 165.181 -4,52
2020-07-07 2020-07-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 10.000 178.209 5,94 8,50 85.000 1.514.776
2020-07-07 2020-07-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 17.257 168.209 11,43 11,81 203.805 1.986.548
2020-07-07 2020-07-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 7.819 150.952 5,46 22,14 173.113 3.342.077
2020-07-02 2020-07-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.109 143.133 -1,45 55,48 -117.007 7.941.019
2020-07-02 2020-07-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -21.049 145.242 -12,66 54,56 -1.148.433 7.924.404
2020-03-31 2020-03-30 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -2.106 0 -100,00
2020-03-31 2020-03-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.106 166.291 -1,25 28,18 -59.347 4.686.080
2020-03-31 2020-03-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 2.106 168.397 1,27 12,94 27.252 2.179.057
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 30.014 30.014
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -6.649 166.291 -3,84 36,06 -239.763 5.996.453
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 15.007 172.940 9,50
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 11.640 11.640
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.578 157.933 -1,61 38,25 -98.608 6.040.937
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 5.819 160.511 3,76
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17.260 17.260 -50,00
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -24.649 49.299 -33,33
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -27.179 154.692 -14,94 36,10 -981.162 5.584.381
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 19.014 181.871 11,68
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 41.909 162.857 34,65
2020-01-07 2020-01-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 36.284 36.284
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 0 -100,00
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.528 118.579 -6,71 26,84 -228.892 3.182.660
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 127.107 17,85
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.425 107.857 -7,25 21,54 -181.474 2.323.240
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
A - Award 19.014 116.282 19,55
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
M - Exercise -17.259 34.520 -33,33
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -7.962 97.268 -7,57 20,39 -162.345 1.983.295
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 17.259 105.230 19,62
2019-01-08 2019-01-04 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 73.948 73.948
2018-09-13 2018-09-12 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3.925 0 -100,00
2018-09-13 2018-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -1.739 87.971 -1,94 20,91 -36.362 1.839.474
2018-09-13 2018-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 3.925 89.710 4,58
2018-05-21 2018-05-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -16.075 0 -100,00
2018-05-21 2018-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -7.122 85.785 -7,67 15,11 -107.613 1.296.211
2018-05-21 2018-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 16.075 92.907 20,92
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 51.779 51.779
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 19.250 -50,00
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.528 76.832 -9,99 13,86 -118.198 1.064.892
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 85.360 29,12
2017-09-13 2017-09-12 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3.925 3.925 -50,00
2017-09-13 2017-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -1.841 66.110 -2,71 13,42 -24.706 887.196
2017-09-13 2017-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 3.925 67.951 6,13
2017-05-22 2017-05-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -16.075 16.075 -50,00
2017-05-22 2017-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -7.347 62.597 -10,50 10,50 -77.144 657.268
2017-05-22 2017-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 16.075 69.944 29,84
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 38.500 -33,33
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.798 53.869 -14,04 14,56 -128.099 784.333
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 62.667 44,34
2016-09-13 2016-09-12 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3.925 7.850 -33,33
2016-09-13 2016-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -1.644 43.612 -3,63 18,89 -31.055 823.831
2016-09-13 2016-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 3.925 45.256 9,50
2016-05-20 2016-05-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -16.075 32.150 -33,33
2016-05-20 2016-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -5.000 39.281 -11,29 14,61 -73.050 573.895
2016-05-20 2016-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 16.075 44.281 56,99
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 57.750 -25,00
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -5.987 28.206 -17,51 16,32 -97.708 460.322
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 34.193 128,82
2015-09-15 2015-09-12 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3.925 11.775 -25,00
2015-09-15 2015-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -1.794 14.180 -11,23 28,99 -52.008 411.078
2015-09-15 2015-09-12 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 3.925 15.974 32,58
2015-05-21 2015-05-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -16.075 48.225 -25,00
2015-05-21 2015-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -7.270 10.761 -40,32 29,22 -212.429 314.436
2015-05-21 2015-05-19 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 16.075 18.031 821,83
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 558.000 558.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 186.000 186.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 77.000 77.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 173.000 173.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 15.700 15.700
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 64.300 64.300
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 17.700 17.700
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 10.000 10.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 72.300 72.300
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 2.106 2.106
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)